Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
This dosing provides robust pituitary stimulation without overwhelming the system, produces measurable IGF-1 increases of 40-100 ng/mL in responsive patients, and generates noticeable improvements in sleep, energy, body composition, and other markers
AOD-9604 Jump to: Structure | Mechanism | Studies | Pharmacokinetics | Protocols | Limitations | Lead Researcher | References AOD-9604 Peptide Molecular Structure & Chemical Properties AOD-9604 represents a pioneering approach to peptide-based metabolic research, originally developed in the 1990s at Monash University in Australia as a potential anti-obesity therapeutic
Further research on GHK-Cu reveals its presence in human blood plasma, urine, and saliva
This time-release matrix uses ingredients like hydroxypropyl methylcellulose and fenugreek-derived galactomannans to gradually release glutathione over time
